CA
MDCO

Cetera Advisors’s Medicines Co MDCO Stock Holding History

Cetera Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10,242
Closed -$384K – 833
2016
Q3 		$384K Sell
10,242
-308
-3% -$11.6K 0.03% 495
2016
Q2 		$358K Buy
+10,550
New +$372K 0.03% 522
2015
Q3 		– Sell
-31,043
Closed -$886K – 760
2015
Q2 		$886K Buy
31,043
+1,621
+6% +$45.2K 0.08% 271
2015
Q1 		$820K Buy
+29,422
New +$826K 0.08% 290

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Cetera Advisors's MDCO Position: Q4 2016 in Review

Cetera Advisors sold out of Medicines Co (MDCO) in Q4 2016, closing a stake of 10,242 shares — an estimated $384K sold.

Cetera Advisors first reported a position in MDCO in Q1 2015 and held it in 4 quarters. The position peaked at $886K in Q2 2015. 195 funds tracked by Wall St. Rank hold MDCO as of Q4 2016.

  • Cetera Advisors reported no remaining Medicines Co position as of Q4 2016 after selling out during the quarter.
  • Cetera Advisors sold 10,242 Medicines Co shares in Q4 2016, an estimated $384K.
  • Cetera Advisors first reported a position in Medicines Co in Q1 2015 and held it in 4 quarters.
  • Cetera Advisors's Medicines Co position peaked at $886K in Q2 2015.
  • 195 funds tracked by Wall St. Rank held Medicines Co as of Q4 2016.

Based on Cetera Advisors's 13F filing for Q4 2016, filed 15 Feb 2017.